Peter M. Fischer

12.4k total citations · 1 hit paper
239 papers, 9.4k citations indexed

About

Peter M. Fischer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Peter M. Fischer has authored 239 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 60 papers in Oncology and 50 papers in Organic Chemistry. Recurrent topics in Peter M. Fischer's work include Cancer-related Molecular Pathways (51 papers), Chemical Synthesis and Analysis (30 papers) and Advanced Database Systems and Queries (22 papers). Peter M. Fischer is often cited by papers focused on Cancer-related Molecular Pathways (51 papers), Chemical Synthesis and Analysis (30 papers) and Advanced Database Systems and Queries (22 papers). Peter M. Fischer collaborates with scholars based in United Kingdom, Germany and Switzerland. Peter M. Fischer's co-authors include David P. Lane, Michael P. Mazanetz, Daniella Zheleva, Shudong Wang, Athos Gianella-Borradori, David A. Barrett, Shao‐Chun Wang, Campbell McInnes, Michael J. Franklin and Yanlei Diao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter M. Fischer

234 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

2013 453 citations Peter M. Fischer, David A. Barrett et al. profile →

Peers

Countries citing papers authored by Peter M. Fischer

Since Specialization

Citations

This map shows the geographic impact of Peter M. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Fischer more than expected).

Fields of papers citing papers by Peter M. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Fischer. The network helps show where Peter M. Fischer may publish in the future.

Co-authorship network of co-authors of Peter M. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Fischer. A scholar is included among the top collaborators of Peter M. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Fischer. Peter M. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Substituted 5-(2-Hydroxybenzoyl)-2-Pyridone Analogues as Inhibitors of the Human Caf1/CNOT7 Ribonuclease 2024 ·Molecules ·(unknown), (unknown), Peter M. Fischer, G. Sebastiaan Winkler	0
2	Distribution of a highly lipophilic drug cannabidiol into different lymph nodes following oral administration in lipidic vehicle 2022 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), (unknown), Marianne Ashford, Paul Gellert, James Butler, Peter M. Fischer, David J. Scurr, Michael J. Stocks, Pavel Gershkovich	11
3	Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol 2022 ·International Journal of Pharmaceutics ·(unknown), (unknown), Salah Abdelrazig, (unknown), (unknown), (unknown), (unknown), (unknown), David A. Gray, Michael J. Stocks, Cris S. Constantinescu, David A. Barrett, Peter M. Fischer, Pavel Gershkovich	15
4	Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers 2020 ·ACS Pharmacology & Translational Science ·Jillian G. Baker, Christophe Fromont, (unknown), Kevin S. J. Thompson, Barrie Kellam, Stephen J. Hill, Sheila M. Gardiner, Peter M. Fischer	4
5	Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics 2019 ·Acta Crystallographica Section D Structural Biology ·Monika Pathak, (unknown), Chan Li, (unknown), (unknown), Benny Danilo Belviso, (unknown), Ingrid Dreveny, Peter M. Fischer, Lodewijk V. Dekker, Maria Luiza Vilela Oliva, Jonas Emsley	16
6	Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B 2018 ·Science ·Alisa Zyryanova, Félix Weis, Alexandre Faille, (unknown), Ana Crespillo-Casado, Yusuke Sekine, Heather P. Harding, Felicity Allen, Leopold Parts, Christophe Fromont, Peter M. Fischer, Alan J. Warren, David Ron	135
7	Learning-to-Rank in Research Paper CBF recommendation: Leveraging Irrelevant Papers. 2016 ·OPUS (Augsburg University) ·(unknown), (unknown), Peter M. Fischer, Georg Lausen	3
8	Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma 2016 ·Journal of Chromatography B ·Jong Bong Lee, Atheer Zgair, Tae Hwan Kim, Min Gi Kim, Sun Dong Yoo, Peter M. Fischer, Pavel Gershkovich	17
9	PubRec: Recommending Publications Based on Publicly Available Meta-Data. 2015 ·OPUS (Augsburg University) ·(unknown), Víctor Ayala, Peter M. Fischer, Georg Lausen	6
10	RDF Constraint Checking 2015 ·OPUS (Augsburg University) ·Peter M. Fischer, Georg Lausen, Alexander Schätzle, Michael Schmidt	1
11	Discovery, synthesis and biochemical profiling of purine-2,6-dione derivatives as inhibitors of the human poly(A)-selective ribonuclease Caf1 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Peter M. Fischer, G. Sebastiaan Winkler	12
12	A Cy5-Labeled S100A10 Tracer Used to Identify Inhibitors of the Protein Interaction With Annexin A2 2010 ·Assay and Drug Development Technologies ·Chan Li, Tummala Rama Krishna Reddy, Peter M. Fischer, Lodewijk V. Dekker	12
13	Nuclear Science Symposium Conference Record (NSS/MIC), 2009 IEEE 2009 ·Volkmar Schulz, Torsten Solf, Bjoern Weissler, Pierre Gebhardt, Peter M. Fischer, M. Ritzert, (unknown), C. Piemonte, N. Zorzi, M. Melchiorri, Stefaan Vandenberghe, Vincent Keereman, Tobias Schaeffter, Paul Marsden	57
14	Gold‐Catalyzed Benzylic CH Activation at Room Temperature 2007 ·Angewandte Chemie International Edition ·A. Stephen K. Hashmi, Sascha Schäfer, M. Wölfle, César Díez‐Gil, Peter M. Fischer, Antonio Laguna, M. Carmen Blanco, M. Concepción Gimeno	144
15	REPLACE: A Strategy for Iterative Design of Cyclin‐Binding Groove Inhibitors 2006 ·ChemBioChem ·(unknown), George Kontopidis, Campbell McInnes, Andrew Plater, (unknown), Angela Cowan, Philip J. Jewsbury, Peter M. Fischer	35
16	Differential Binding of Inhibitors to Active and Inactive CDK2 Provides Insights for Drug Design 2006 ·Chemistry & Biology ·George Kontopidis, Campbell McInnes, (unknown), I.W. McNae, (unknown), Mokdad Mezna, Mark Thomas, Gavin Wood, Shudong Wang, Malcolm D. Walkinshaw, Peter M. Fischer	49
17	New approaches to cancer therapies 1999 ·The Journal of Pathology ·Robin Fåhræus, Peter M. Fischer, Eberhard Krausz, David P. Lane	19
18	Exploring JDBC's potential 1998 ·Peter M. Fischer	1
19	Application of arylsulphonyl side‐chain protected arginines in solid‐phase peptide synthesis based on 9‐ fluorenylmethoxycarbonyl amino protecting strategy 1992 ·International journal of peptide & protein research ·Peter M. Fischer, (unknown), Margaret I. Tyler, M.E.H. Howden	9
20	Introduction: toward a psychophysics of hypermedia 1990 ·Springer eBooks ·Peter M. Fischer, Heinz Mandl	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact